Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual

Feb 18, 2025 1:00 PM - Feb 20, 2025 5:00 PM

(Central Europe Standard Time)

EudraVigilance Data Analysis System (EVDAS): Practical Approach on Use for Signal Management in the EU

This virtual live training course will teach concepts, access policy, and use of the EudraVigilance Data Analysis System (EVDAS) for signal detection.

Overview

This virtual live training course will teach concepts, access policy, and use of the EudraVigilance Data Analysis System (EVDAS) for signal detection. Experienced trainers using EVDAS on a regular basis will share practical advice on how to download and interpret the data and use it for signal detection.

The EudraVigilance data analysis system (EVDAS) supports EU pharmacovigilance safety monitoring activities with the focus on signal detection and evaluation of ICSRs. Marketing authorisation holders with active substances included in the list published by the European Medicines Agency have to monitor and inform authorities of validated signals with their medicines. GVP Module VII "Periodic Safety Update Reports" states that also for other active substances, MAHs are expected to include data from EudraVigilance whenever there are signal evaluations in the PSUR triggered by other sources of information.

The course is based on the latest guidelines on EU Good Pharmacovigilance Practices (GVP): Module IX – Signal management, Commission Implementing Regulation (EU) No. 520/2012. Time has been set aside for practical exercises, questions, and discussions.

Featured topics

    • GVP IX and Addendum I
    • Screening for adverse reactions in EudraVigilance (EV)
    • Principles of access in EV
    • Practical use of EVDAS
    • eRMR analysis and documentation
    • Line listing analysis
    • CMDh list of safety concerns
    • Referrals page on the EMA website
    • List of signals discussed by the PRAC since 2012
    • How to escalate signals, e.g. stand-alone notification, ESI

Who should attend?

  • This course is designed for professionals involved in:

    • Pharmacovigilance (including QPPVs)
    • Drug Safety and Patient Safety Risk Management
    • Information Technology
    • Pharmacovigilance Data Management
    • Pharmacovigilance Consultancies
    • Quality and Compliance

     

  • Course level: Intermediate, for professionals with 2-3 years of experience in Pharmacovigilance who work in the area of signal management but have no or limited experience on how to use EVDAS for signal detection.

Learning objectives

  • At the conclusion of this virtual live training course, participants will be able to:

    • Identify regulatory requirements for Signal Management in Europe (GVP IX and Addendum I)
    • Describe principles of screening EudraVigilance for adverse reactions and the EudraVigilance data access policy
    • Identify levels and methods of access to Individual Case Safety Reports (ICSRs) data and understand the terminology of EVDAS
    • Discuss the use of active substance grouping reports, and electronic reaction monitoring reports (eRMRs)
    • Analyse eRMRs with various reference periods and line listings and document your assessments
    • Identify potential signals and know how to escalate them to the National Competent Authorities (NCAs) and the European Medicines Agency (EMA)

Digital Learning Catalog

DIA Learning: eLearning Soultions
Download

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.